ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0793

Topological Laser Capture Microscopy (LCM)-RNAseq to Map the Rheumatoid Arthritis (RA) Synovial Transcriptome

Benjamin Van Espen1, Andrew Wilson1, Gregory Seumois2, Narayanan Perumal3, Robert Benschop4, Gary Firestein5, Nunzio Bottini5 and Stephanie Stanford1, 1University of California, San Diego, La Jolla, 2La Jolla Institute for Immunology, La Jolla, 3Eli Lilly, Indianapolis, 4Eli Lilly and Company, Indianapolis, IN, 5University of California, San Diego, La Jolla, CA

Meeting: ACR Convergence 2020

Keywords: Fibroblasts, Synovial, Pathology Bone Joint, rheumatoid arthritis, Synovitis

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Saturday, November 7, 2020

Session Title: RA – Etiology & Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Understanding pathogenic processes in the diseased tissue in rheumatoid arthritis (RA) is a critical step to defining disease pathogenesis and identifying novel therapeutic targets. However, the use of enzymatically dispersed cells can lead to changes in the gene transcription and bias due to cell death. Therefore, we established laser capture microscopy followed by RNAseq (LCM-RNAseq) to study the regional transcriptome.

Methods: Synovial tissue was captured by LCM after H&E staining from lining, sublining, and blood vessels from 3 RA and 3 osteoarthritis (OA) patients. RNA was extracted and subjected to RNAseq. Principal component analysis (PCA) by disease state was performed on the top 500 most variable genes among the sample set. Analysis of differentially expressed genes (DEGs) between disease state was performed using the Bioconductor DESeq2 package. DEGs had adjusted p-values of < 0.05 and log2 fold change >1 or < -1. Pathway analysis on the unique DEGs for each substructure was performed using the Canonical Pathways function in Ingenuity Pathway Analysis (IPA) platform. The significance of the pathways was calculated using a right-tailed Fisher’s exact test and adjusted using the Benjamini-Hochberg method.

Results: PCA revealed striking separation between RA and OA transcriptomes (see Figure), indicating that the transcriptomes could be readily distinguished. Pairwise comparisons of synovial lining, sublining and blood vessels between RA and OA revealed substantial differences in transcriptional patterns between each region. Pathway analysis of DEGs unique to each substructure revealed that each region displayed distinct phenotypic abnormalities in RA. For example, RA synovial lining was marked by anomalies of innate immunity, including Role of Pattern Recognition Receptors in Recognition of Bacteria and Virus (p< 0.001) and LPS/IL-1 Mediated Inhibition of RXR Function (p< 0.01) pathways. Intriguingly, RA sublining abnormalities were primarily in metabolic pathways involving fatty acid regulation, such as Fatty Acid Activation (p< 0.01) and Mitochondrial L-carnitine Shuttle Pathway (p< 0.01). RA synovial vessels displayed evidence of alterations in pathways indicative of dysregulated angiogenesis, including Melatonin Signaling (p< 0.0001) and Apelin Cardiomyocyte Signaling (p< 0.001).

Conclusion: Through use of LCM, we established a method for RNAseq-quality extraction of RNA and showed large differences between RA and OA synovial substructures that are difficult to detect using single cell analysis. This technology can supplement disaggregation techniques to provide key information on in situ gene expression profiles and identify disease and substructure-specific targets for RA.


Disclosure: B. Van Espen, Eli Lilly, 2; A. Wilson, Eli Lilly, 2; G. Seumois, None; N. Perumal, Eli Lilly and Company, 1, 3; R. Benschop, Eli Lilly and Company, 1, 3, 4; G. Firestein, Eli Lilly, 2; N. Bottini, Gilead Sciences, 2, Kyowa Kirin Pharmaceutical Research, 2, Eli Lilly, 2; S. Stanford, Eli Lilly, 2.

To cite this abstract in AMA style:

Van Espen B, Wilson A, Seumois G, Perumal N, Benschop R, Firestein G, Bottini N, Stanford S. Topological Laser Capture Microscopy (LCM)-RNAseq to Map the Rheumatoid Arthritis (RA) Synovial Transcriptome [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/topological-laser-capture-microscopy-lcm-rnaseq-to-map-the-rheumatoid-arthritis-ra-synovial-transcriptome/. Accessed March 8, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/topological-laser-capture-microscopy-lcm-rnaseq-to-map-the-rheumatoid-arthritis-ra-synovial-transcriptome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.